Pfizer News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

14.12.23	: Pfizer price target reduced to $36 from $42 at Truist Securities (MarketWatch)
14.12.23	Pfizer Completes Acquisition of Seagen (Businesswire)
14.12.23	Apple, Adobe, Pfizer, Alibaba, Tesla: Why These 5 Stocks Are On Investors' Radars Today (Benzinga)
13.12.23	Pfizer: pharma group needs weight loss drug to secure post-Covid future (Financial Times)
13.12.23	Why Pfizer Stock Is Sinking Today (MotleyFool)
13.12.23	Pfizer Issues FY24 Forecast, Joins Target Hospitality, Southwest Airlines And Other Big Stocks Moving Lower On Wednesday (Benzinga)
13.12.23	: Pfizer premarket trading volume tops 6.3 million shares as most active (MarketWatch)
13.12.23	Pfizer shares tumble on weak forecast for 2024 revenues (Financial Times)
13.12.23	: Pfizer most active stock with volume of 2.7 million shares, according to MarketWatch Premarket Screener (MarketWatch)
13.12.23	Why Is US Pharma Giant Pfizer Stock Trading Lower Today? (Benzinga)
13.12.23	: Pfizer sets guidance for 2024, sees revenue of $58.5 bln to $61.5 bln; FactSet consensus $62.6 bln (MarketWatch)
13.12.23	Pfizer Provides Full-Year 2024 Guidance (Businesswire)
12.12.23	Pfizer Clears Required Regulatory Hurdles To Complete $43B Seagen Acquisition (Benzinga)
12.12.23	Pharmakonzern: Pfizer kann Seagen-Zukauf für 43 Milliarden Dollar abschliessen (Handelsblatt)
12.12.23	: Pfizer expects to close Seagen deal on Thursday, will create a new oncology division to incorporate company (Market Watch)
12.12.23	Pfizer Receives All Required Regulatory Approvals to Complete the Acquisition of Seagen (Businesswire)
10.12.23	Marstacimab Phase 3 Data Presented at ASH 2023 Demonstrate Significant Bleed Reduction in Hemophilia A and B (Businesswire)
08.12.23	European Commission Approves Pfizer’s ELREXFIO® for Relapsed and Refractory Multiple Myeloma (Businesswire)
01.12.23	Pfizer Announces Topline Phase 2b Results of Oral GLP-1R Agonist, Danuglipron, in Adults with Obesity (Businesswire)
21.11.23	Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference (Businesswire)
17.11.23	Aktienempfehlungen konträr: Diese Low-Performer könnten die Top-Aktien 2024 werden (finanzen.ch) Mark Hulbert verrät, welche Low-Performer aus dem laufenden Jahr zu Top-Titeln 2024 werden könnten.» mehr
02.11.23	Pfizer Highlights Scientific Advances from Growing Hematology Portfolio at American Society of Hematology Annual Meeting (Businesswire)
02.11.23	Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference (Businesswire)
02.11.23	Die Top 10 der grössten Übernahmen der Geschichte (finanzen.ch) AT&T, Pfizer und die Walt Disney Company haben eines gemeinsam: Sie zahlten hohe Summen, um andere Konzerne zu übernehmen.» mehr
31.10.23	Pfizer Reports Third-Quarter 2023 Results (Businesswire)
26.10.23	Pfizer and BioNTech Announce Positive Topline Data for mRNA-based Combination Vaccine Program Against Influenza and COVID-19 (RSS)
26.10.23	Pfizer and BioNTech Announce Positive Topline Data for mRNA-based Combination Vaccine Program Against Influenza and COVID-19 (Businesswire)
20.10.23	FDA Approves PENBRAYA™, the First and Only Vaccine for the Prevention of the Five Most Common Serogroups Causing Meningococcal Disease in Adolescents (Businesswire)
13.10.23	Pfizer Amends U.S. Government Paxlovid Supply Agreement and Updates Full-Year 2023 Guidance (Businesswire)
12.10.23	U.S. FDA Approves Pfizer’s BRAFTOVI® + MEKTOVI® for BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer (Businesswire)
05.10.23	Pfizer Presents New Data at IDWeek 2023 Highlighting Advances in Prevention and Treatment of Certain Respiratory Illnesses and Other Infectious Diseases (Businesswire)
04.10.23	Pfizer Declares Fourth-Quarter 2023 Dividend (Businesswire)
28.09.23	Pfizer and BioNTech Receive Health Canada Authorization for XBB.1.5-Adapted Monovalent COVID-19 Vaccine (RSS)
22.09.23	Pfizer Broadens Portfolio of Respiratory Vaccines Recommended by CDC Advisory Committee with ABRYSVO™ for RSV (Businesswire)
19.09.23	Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference (Businesswire)
19.09.23	European Commission Approves Pfizer’s LITFULO™ for Adolescents and Adults With Severe Alopecia Areata (Businesswire)
18.09.23	Pfizer Invites Public to View and Listen to Webcast of October 31 Conference Call with Analysts (Businesswire)
12.09.23	Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference (Businesswire)
11.09.23	Pfizer and BioNTech Receive U.S. FDA Approval for 2023-2024 COVID-19 Vaccine (RSS)
11.09.23	Pfizer and BioNTech Receive U.S. FDA Approval for 2023-2024 COVID-19 Vaccine (Businesswire)
08.09.23	NYSE-Titel Pfizer-Aktie: Was Analysten im August vom Papier halten (finanzen.net) Das sind die Einschätzungen der Experten für die Pfizer-Aktie.» mehr
05.09.23	Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Swiss Re	133.90	4.77 %	K V
Swiss Life Hldg	693.00	0.84 %	K V
Zurich Insur Gr	552.40	0.84 %	K V
Kuehne+Nagel Int	206.50	0.73 %	K V
Sonova Hldg	294.20	0.65 %	K V
Sika	227.80	-1.21 %	K V
Part Grp Hldg	1’264.50	-1.56 %	K V
Geberit	538.20	-1.61 %	K V
Alcon	75.22	-1.75 %	K V
Lonza Grp	534.40	-2.52 %	K V

Nachrichten zu Pfizer Inc Cert.Deposito Arg.Repr. 0.5 Shs

Aktien Top/Flop

Pfizer Peer Group Nachrichten

Meistgelesene Nachrichten